Search

Your search keyword '"Mihajlo, B"' showing total 419 results

Search Constraints

Start Over You searched for: Author "Mihajlo, B" Remove constraint Author: "Mihajlo, B"
419 results on '"Mihajlo, B"'

Search Results

2. Predictors of loss due to pharmaceutical fraud: evidence from the U.S.

4. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

5. The burden of disease in Greece, health loss, risk factors, and health financing, 2000–16: an analysis of the Global Burden of Disease Study 2016

6. Dynamics of Health Care Financing and Spending in Serbia in the XXI Century

7. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

8. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016

9. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016

10. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

11. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

12. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

13. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015

14. Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries

15. Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries

16. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015

17. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

18. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

19. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

20. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

21. Dissolution behaviour of a polyphosphate glass in simulated body fluid

22. The influence of sociodemographic factors on the use of antihypertensive drugs among adults in Serbia: Cross-sectional study

23. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015

24. Effect of La2O3 on the structure and the properties of strontium borate glasses

25. Cost-effectiveness of depressive episode pharmacological treatment

26. Structural validity and reliability of the healthcare professionals' economic reasoning questionnaire

28. Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market

29. Is 28-day follow-up period enough for examining the mortality after resuscitation with human albumin?

31. Direct medical costs of COPD diagnosis and treatment, Eastern vs Western European country – examples of Serbia and Belgium

32. Preparation of glass-ceramic in Li2O-Al2O3-GeO2-P2O5 system

34. Edaravone May Prevent Ferroptosis in ALS

35. Crystallization behaviour of Li2O·Nb2O5·SiO2 glass containing TiO2

36. Introduction of the interdependence between the glutathione half-cell reduction potential and thermodynamic parameters during accelerated aging of maize seeds

37. The growth of maize seedlings as function of free energy and redox potential

38. Complexity of free radical metabolism in human erythrocytes

39. Crystal growth of K2TiGe3O9 in the glass

40. Potential role of hydrogen peroxide and melanin in the cold hardiness of Ostrinia nubilalis (Lepidoptera: Pyralidae)

41. Assessment of diabetes mellitus type 2 treatment costs in the Republic of Serbia

42. Redox regulation of cell cycle through nitric oxide

44. Does cholesterol bound to haemoglobin affect the anti-oxidant enzyme defence system in human erythrocytes?

45. Does cholesterol bound to haemoglobin affect the anti-oxidant enzyme defence system in human erythrocytes?

46. Activity of antioxidative defense enzymes in the blood of patients with liver echinococcosis

48. BIOEQUIVALENCE STUDIES

50. Manganese superoxide dismutase (MnSOD) catalyzes NO-dependent tyrosine residue nitration

Catalog

Books, media, physical & digital resources